Tanya Rhodes - Medovex Corp Chief Officer
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Insider
Tanya Rhodes is Chief Officer of Medovex Corp
| Age | 62 |
| Phone | 888 664 2983 |
| Web | https://www.hcyte.com |
Medovex Corp Management Efficiency
The company has return on total asset (ROA) of (3.4756) % which means that it has lost $3.4756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5969) %, meaning that it created substantial loss on money invested by shareholders. Medovex Corp's management efficiency ratios could be used to measure how well Medovex Corp manages its routine affairs as well as how well it operates its assets and liabilities.Medovex Corp currently holds 3.88 M in liabilities with Debt to Equity (D/E) ratio of 2.61, implying the company greatly relies on financing operations through barrowing. Medovex Corp has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Medovex Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Medovex Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medovex Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medovex to invest in growth at high rates of return. When we think about Medovex Corp's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Rolf Srensen | Bavarian Nordic AS | N/A | |
| Paul MSc | Bavarian Nordic AS | 56 | |
| Joseph Hazelton | Dyadic International | 48 | |
| Jinzi Wu | Ascletis Pharma | 60 | |
| Elisabet Pinos | Aura Biosciences | 50 | |
| MBA MBA | Antibe Therapeutics | N/A | |
| Ming CPA | Ascletis Pharma | N/A | |
| MBA MD | Monopar Therapeutics | 38 | |
| Russell Thirsk | Bavarian Nordic AS | N/A | |
| CPE MBA | Aura Biosciences | 57 | |
| Florian M | GH Research PLC | 55 | |
| Christina BBA | Antibe Therapeutics | N/A | |
| Magnus Halle | GH Research PLC | 27 | |
| George Hill | Ascletis Pharma | 72 | |
| John MBA | Ascletis Pharma | N/A | |
| Kristjan Gudmundsson | Ascletis Pharma | 55 | |
| Handan He | Ascletis Pharma | 61 | |
| Anu Kerns | Bavarian Nordic AS | 51 | |
| Hejingdao Wu | Ascletis Pharma | 49 | |
| JeanChristophe May | Bavarian Nordic AS | 56 | |
| Michele MBA | Aura Biosciences | N/A | |
Management Performance
| Return On Equity | -4.6 | |||
| Return On Asset | -3.48 |
Medovex Corp Leadership Team
Elected by the shareholders, the Medovex Corp's board of directors comprises two types of representatives: Medovex Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medovex. The board's role is to monitor Medovex Corp's management team and ensure that shareholders' interests are well served. Medovex Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medovex Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Controller Officer | ||
| Michael Yurkowsky, CEO Director | ||
| Jeremy Daniel, Chief Officer | ||
| Tanya Rhodes, Chief Officer |
Medovex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Medovex Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |